Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PLEKHM2 antisense RNA 1 (PLEKHM2-AS1) is a long non-coding RNA gene located antisense to the protein-coding gene PLEKHM2. As an antisense lncRNA, it may play a role in the post-transcriptional or epigenetic regulation of the PLEKHM2 gene, analogous to other antisense lncRNAs that modulate gene stability, expression, or chromatin state[2]. However, there is currently no direct experimental evidence describing its biological function, its disease relevance, or its candidacy as a therapeutically actionable target. The molecule is distinguished from canonical drug targets by its non-protein coding nature and lack of direct disease associations. Thus, PLEKHM2-AS1 is best classified as a genomic regulatory RNA with largely uncharacterized function and no current pharmacological targeting or biomarker status[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PLEKHM2 antisense RNA 1 (PLEKHM2-AS1).